[go: up one dir, main page]

DK2197492T3 - Hidtil ukendte præparater på basis af taxoider - Google Patents

Hidtil ukendte præparater på basis af taxoider

Info

Publication number
DK2197492T3
DK2197492T3 DK08868434.5T DK08868434T DK2197492T3 DK 2197492 T3 DK2197492 T3 DK 2197492T3 DK 08868434 T DK08868434 T DK 08868434T DK 2197492 T3 DK2197492 T3 DK 2197492T3
Authority
DK
Denmark
Prior art keywords
taxoids
preparations based
known preparations
newly known
newly
Prior art date
Application number
DK08868434.5T
Other languages
English (en)
Inventor
Carine Gachon
Patricia Rortais
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK2197492T3 publication Critical patent/DK2197492T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
DK08868434.5T 2007-10-10 2008-10-09 Hidtil ukendte præparater på basis af taxoider DK2197492T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0707092A FR2922107B1 (fr) 2007-10-10 2007-10-10 Nouvelles compositions a base de taxoides
PCT/FR2008/001410 WO2009083664A1 (fr) 2007-10-10 2008-10-09 Nouvelles compositions a base de taxoides

Publications (1)

Publication Number Publication Date
DK2197492T3 true DK2197492T3 (da) 2012-03-12

Family

ID=39356621

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08868434.5T DK2197492T3 (da) 2007-10-10 2008-10-09 Hidtil ukendte præparater på basis af taxoider

Country Status (38)

Country Link
US (1) US8481589B2 (da)
EP (1) EP2197492B1 (da)
JP (1) JP5574965B2 (da)
KR (1) KR20100075490A (da)
CN (1) CN101820918A (da)
AR (1) AR072333A1 (da)
AT (1) ATE534406T1 (da)
AU (1) AU2008345527A1 (da)
BR (1) BRPI0818597A2 (da)
CA (1) CA2701789A1 (da)
CL (1) CL2008003002A1 (da)
CO (1) CO6260107A2 (da)
CR (1) CR11335A (da)
CY (1) CY1112388T1 (da)
DK (1) DK2197492T3 (da)
DO (1) DOP2010000098A (da)
EA (1) EA016619B1 (da)
ES (1) ES2377352T3 (da)
FR (1) FR2922107B1 (da)
GT (1) GT201000075A (da)
HR (1) HRP20120165T1 (da)
IL (1) IL204950A0 (da)
MA (1) MA31840B1 (da)
MX (1) MX2010003914A (da)
NI (1) NI201000048A (da)
NZ (1) NZ584544A (da)
PA (1) PA8798101A1 (da)
PE (1) PE20090962A1 (da)
PL (1) PL2197492T3 (da)
PT (1) PT2197492E (da)
RS (1) RS52131B (da)
SI (1) SI2197492T1 (da)
TN (1) TN2010000129A1 (da)
TW (1) TW200922552A (da)
UA (1) UA97418C2 (da)
UY (1) UY31386A1 (da)
WO (1) WO2009083664A1 (da)
ZA (1) ZA201002504B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120065255A1 (en) * 2009-10-19 2012-03-15 Nagesh Palepu Cabazitaxel formulations and methods of preparing thereof
PL2493466T3 (pl) 2009-10-29 2021-11-15 Sanofi Mature Ip Nowe przeciwguzowe zastosowanie kabazytakselu
MX341082B (es) 2010-05-03 2016-08-08 Teikoku Pharma Usa Inc Formulaciones de pro-emulsion de taxano no acuosas y metodos para hacer y usar las mismas.
JP2012051823A (ja) * 2010-08-31 2012-03-15 Fujifilm Corp 難容性薬物含有水中油型乳化組成物及びその製造方法
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN104225615B (zh) * 2014-09-24 2017-02-01 东南大学 一种紫杉醇类磷脂化合物、其药物组合物及应用
EP3384961B1 (en) * 2017-04-05 2021-10-13 RaySearch Laboratories AB System and method for modelling of dose calculation in radiotherapy treatment planning

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
US5750561A (en) * 1991-07-08 1998-05-12 Rhone-Poulenc Rorer, S.A. Compositions containing taxane derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー 7,8−シクロプロパタキサン類
FR2698543B1 (fr) 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US6372780B2 (en) * 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
TR200100575T2 (tr) * 1998-08-20 2001-07-23 Aventis Pharma S.A. Taksoid türevlerinin yeni kullanım alanları
US20020001613A1 (en) * 2000-02-08 2002-01-03 Susan Niemiec Method of manufacturing liposomes
US20030099674A1 (en) * 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
EP1617818A1 (en) * 2003-04-29 2006-01-25 Baxter International Inc. Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
EP1498120A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid formulations for the oral administration of taxoids
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
JP5089887B2 (ja) * 2006-01-23 2012-12-05 日本精化株式会社 生理活性物質含有複合体

Also Published As

Publication number Publication date
ATE534406T1 (de) 2011-12-15
UY31386A1 (es) 2009-05-29
WO2009083664A1 (fr) 2009-07-09
BRPI0818597A2 (pt) 2015-04-22
EA201070448A1 (ru) 2010-08-30
PA8798101A1 (es) 2009-07-23
DOP2010000098A (es) 2010-04-30
SI2197492T1 (sl) 2012-03-30
CR11335A (es) 2010-08-13
RS52131B (sr) 2012-08-31
PL2197492T3 (pl) 2012-05-31
US20100311825A1 (en) 2010-12-09
PE20090962A1 (es) 2009-08-10
UA97418C2 (ru) 2012-02-10
EP2197492B1 (fr) 2011-11-23
EA016619B1 (ru) 2012-06-29
HRP20120165T1 (hr) 2012-03-31
ZA201002504B (en) 2011-06-29
KR20100075490A (ko) 2010-07-02
MA31840B1 (fr) 2010-11-01
AU2008345527A1 (en) 2009-07-09
IL204950A0 (en) 2010-11-30
TN2010000129A1 (fr) 2011-09-26
US8481589B2 (en) 2013-07-09
WO2009083664A8 (fr) 2010-05-14
GT201000075A (es) 2012-04-11
FR2922107A1 (fr) 2009-04-17
PT2197492E (pt) 2012-02-20
TW200922552A (en) 2009-06-01
JP2011500542A (ja) 2011-01-06
CN101820918A (zh) 2010-09-01
NI201000048A (es) 2010-08-20
ES2377352T3 (es) 2012-03-26
CY1112388T1 (el) 2015-12-09
NZ584544A (en) 2012-04-27
JP5574965B2 (ja) 2014-08-20
CL2008003002A1 (es) 2009-10-16
CO6260107A2 (es) 2011-03-22
AR072333A1 (es) 2010-08-25
EP2197492A1 (fr) 2010-06-23
MX2010003914A (es) 2010-05-17
FR2922107B1 (fr) 2010-02-26
CA2701789A1 (fr) 2009-07-09

Similar Documents

Publication Publication Date Title
EP2180160A4 (en) TURBOCHARGER
EP2226484A4 (en) TURBOCHARGER
LU92600I2 (fr) Sovaldi (sofosbuvir)
EP2170350A4 (en) SUBSTITUTED IMIDAZOHETEROCYCLES
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
BRPI0821573A2 (pt) benzofuropirimidonas
ATE501136T1 (de) Imidazopyridinone
EP2233838A4 (en) COOKER
ATE514696T1 (de) Diphenyl-dihydro-imidazopyridinone
DK2132326T3 (da) Fremgangsmåder
UY3822Q (es) Epiladora
DK2111555T3 (da) Diagnosticering af præeklampsi
BRPI0814519A2 (pt) Organopolissiloxano
BRPI0811451A2 (pt) Exopolissacarídeo
EP2350385A4 (en) Forming section
BRPI0815547A2 (pt) Depsipeptídeos cícliocos
AT505058A3 (de) Türschliesssystem
DE112009001577A5 (de) Verstellpumpe
DK2197492T3 (da) Hidtil ukendte præparater på basis af taxoider
DE112008001216A5 (de) Magnetronplasmaanlage
BRPI0908866A2 (pt) mastiques
ATE506032T1 (de) Endoprothesenkomponente
DE112008002200A5 (de) Sperrsynchronisiervorrichtung
CU20090155A7 (es) Macrolidos
DE112008001534A5 (de) Anreihgussform